BEIJING,Sept. 2,2024-- On August 30th,CMG Voice of the South China Sea released the first documentary on the ecological survey of Xianbin Jiao,titled "If Xianbin Jiao Could Speak".
DONGGUAN,China,Sept. 2,2024-- QCY,a leading brand in innovative audio solutions,introduces the Crossky C30 Clip-On Open Earbuds. This breakthrough audio wearable features an innovative C-shaped desig
HONG KONG,Sept. 2,2024-- AXA Hong Kong & Macau ("AXA") has been offering integrated solutions across Life,Health,and General Insurance to the public and is committed to being a holistic
TOKYO,Aug. 28,2024-- KLab Inc.,a leader in online mobile games,announced that its hit 3D action game Bleach: Brave Souls has reached a total of 95 million downloads* worldwide. See the original press
PORT VILA,Vanuatu,Aug. 28,2024-- Vantage Markets (or "Vantage") is thrilled to announce its recognition at the prestigious International Business Magazine Awards 2024,where the company secu
QINGDAO,China,Aug. 29,2024-- On the morning of August 28,the FifthQingdao Multinationals Summit,jointly organized by the Ministry of Commerce of China and the People\'s Government of Shandong Provinc
TOKYO,Aug. 29,2024-- LOTTE Holdings Co.,Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("CVC")
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
